Hunter C Smith - Net Worth and Insider Trading

Hunter C Smith Net Worth

The estimated net worth of Hunter C Smith is at least $12 Million dollars as of 2026-09-06. Hunter C Smith is the CFO of Rhythm Pharmaceuticals Inc and owns about 114,024 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $12 Million. Details can be seen in Hunter C Smith's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hunter C Smith has not made any transactions after 2026-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Hunter C Smith

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Hunter C Smith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hunter C Smith owns 3 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , Genesee & Wyoming Inc (GWR) , and Spyre Therapeutics Inc (SYRE) .

Click here to see the complete history of Hunter C Smith’s form 4 insider trades.

Insider Ownership Summary of Hunter C Smith

Ticker Company Transaction Date Type of Owner
RYTM Rhythm Pharmaceuticals Inc 2026-08-31 CFO and Treasurer
GWR Genesee & Wyoming Inc 2019-12-30 director
SYRE Spyre Therapeutics Inc 2021-11-12 director

Hunter C Smith Latest Holdings Summary

Hunter C Smith currently owns a total of 1 stock. Hunter C Smith owns 114,024 shares of Rhythm Pharmaceuticals Inc (RYTM) as of August 31, 2026, with a value of $12 Million.

Latest Holdings of Hunter C Smith

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RYTM Rhythm Pharmaceuticals Inc 2026-08-31 114,024 102.74 11,714,826

Holding Weightings of Hunter C Smith


Hunter C Smith Form 4 Trading Tracker

According to the SEC Form 4 filings, Hunter C Smith has made a total of 22 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 22 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 62,774 shares on August 31, 2026, which brought Hunter C Smith around $7 Million.

Insider Trading History of Hunter C Smith

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hunter C Smith Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Hunter C Smith owns.
View RYTM Analysis

Hunter C Smith Ownership Network

Ownership Network List of Hunter C Smith

No Data

Ownership Network Relation of Hunter C Smith

Insider Network Chart


Hunter C Smith Owned Company Details

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Hunter C Smith is the CFO and Treasurer of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Scientific Officer Alastair Garfield , EVP & Head of North America Jennifer Chien , and Chief Technical Officer Joseph Shulman .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Hunter C Smith made 7 insider transaction in Rhythm Pharmaceuticals Inc (RYTM) with a net sale of 178,035. Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,480 shares made by Pamela J. Cramer , a net sale of 65,001 shares made by Joseph Shulman , and a net sale of 17,987 shares made by Christopher Paul German .

In summary, during the past 3 months, insiders sold 245,450 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 245,450 shares. During the past 18 months, 729,965 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 729,965 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

Hunter C Smith Mailing Address

Above is the net worth, insider trading, and ownership report for Hunter C Smith. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Hunter C Smith's mailing address is: Boston Ma 02116.